Alzheimer's disease affects men and women differently, not only in prevalence but also in symptom presentation and progression. Women tend to have a higher risk of developing Alzheimer's, which may be partly attributed to their longer lifespan. Hormonal differences, particularly estrogen levels, have been explored as potential factors influencing this gender disparity.
Moreover, the manifestation of symptoms varies: women often exhibit more memory impairment and verbal difficulties early on, while men may experience more pronounced behavioral changes and visuospatial deficits. These differences impact diagnosis and treatment approaches, underscoring the importance of tailored care strategies. Research continues to delve into the complex interplay of biological, genetic, and social factors to better understand and address Alzheimer's disease in both genders effectively.
Jacqueline Tuppen
Cogs Club, United Kingdom
Yong Xiao Wang
Albany Medical College, United States
Kaoru Sakatani
The University of Tokyo, Japan
Suren A Tatulian
University of Central Florida, United States
Constantina Mizis
The Latino Alzheimer’s and Memory Disorders Alliance, United States
Paul Y Song
NKGen Biotech, United States
Marco Ruggiero
Silver Spring Sagl, Switzerland
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States